Stay updated on Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 removed in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:54:12.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Footer branding updates add 'Moffitt Cancer Center Clinical Trials website' and 'Helpful Links Provided by', and a government funding status notice was removed from the page.
    Difference
    0.6%
    Check dated 2025-11-17T17:49:36.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Core study details appear unchanged; no additions or deletions to the main study information were detected. The overall page structure and key fields such as title, conditions, interventions, outcomes, and eligibility remain the same.
    Difference
    0.4%
    Check dated 2025-11-03T12:32:43.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    3%
    Check dated 2025-10-05T17:19:52.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Updated metadata to reflect a newer version (v3.1.0) and more current dates (2025-09) while removing older metadata (v3.0.2, 2025-05). This signals an updated release cycle and recentness without clear changes to core content.
    Difference
    0.7%
    Check dated 2025-09-28T10:12:49.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T00:17:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.